Image

The Application of the New Magnetic Resonance UTE Technique in Thoracic Lesions

The Application of the New Magnetic Resonance UTE Technique in Thoracic Lesions

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Quantitative characteristic values of lung lesions were obtained by UTE technique, so as to make qualitative diagnosis of benign and malignant lesions. And to explore the clinical feasibility of CT-like technology - high resolution ZTE technology in the diagnosis of pulmonary diseases.

Description

Ultrashort echo time (UTE) sequence can obtain data from T2 for lung imaging before T2 decays in lung parenchyma with extremely short echo time, which makes up for the defect that conventional MRI cannot clearly display short T2 tissue imaging, and can provide more supplementary information for lung CT scan. There has been a lot of research progress in the evaluation of neonatal lung disease, chronic obstructive airway disease and pneumonia. The 3D UTE sequence developed on this basis has made great progress in improving the resolution, signal-to-noise ratio and shortening the scanning time of lung MR Images, and has successfully obtained submillimeter high-resolution images. The purpose of this study was to explore the value of MRI ultra-short echo technology in the qualitative diagnosis of benign and malignant lung lesions, and to explore the clinical application of CT-like technology - high resolution ZTE technology in the lung.

Eligibility

Inclusion Criteria:

  1. Age ≥18 years old;
  2. There are lung lesions, and the solid component is ≥6mm;
  3. Chest CT plain scan or /+ enhanced examination within 4 weeks.

Exclusion Criteria:

  1. There are metal implants in the corresponding parts of the chest;
  2. MRI contrast agent allergy;
  3. Claustrophobia;
  4. Pregnant women;
  5. High fever;
  6. Respiratory failure;
  7. Lung lesion biopsy within 4 weeks prior to examination.

Study details
    Lung Diseases

NCT05998707

Fifth Affiliated Hospital, Sun Yat-Sen University

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.